Talk:Epidural blood patch

To do
DecrepitlyOnward (he/they, fine with any, use as you wish) (talk) 18:26, 23 January 2022 (UTC)
 * Initial treatment outcome of blind vs targeted epidural blood patch for idiopathic intracranial hypotension: systemic approach and meta-analysis, to be published next month

Wiki Education assignment: WikiProject Medicine Fall 2023 UCF COM
— Assignment last updated by Courseedits23 (talk) 22:00, 26 October 2023 (UTC)

Hello, I am a 4th year medical student at the University of Central Florida. As a part of my current course, I am working on editing Wikipedia articles to improve the quality of the free medical information available! This article is currently rated a C-class with mid-importance. I plan to edit this article throughout these next few weeks. Here is my work plan.

Generally – I plan to add more explanations and less medical jargon in the article in order to make it an easier read for the average person.

Introduction: This section is void of citations, so I will expand the intro and add more citations. It has valuable information but needs to be explained in simpler terms.

Uses: Epidural blood patch is most commonly used for severe post-Dural puncture headache. I will add more information on this pathology and the causes.

Effectiveness and complications: I plan to fact-check this and update it with the newest literature, if needed.

Special populations: I plan to research this and add a section if appropriate – per Wikipedia:Manual of Style/Medicine-related articles. — Preceding unsigned comment added by Courseedits23 (talk • contribs) 22:40, 26 October 2023 (UTC)


 * Peer review:
 * Great job improving the introduction and "uses" sections to make them easier to understand. Everything that you have added is relevant to the topic, neutral (free of bias), and information is presented succinctly. Facts are supported by reliable references throughout which are mostly up to date. While some of the references that you added (especially under "uses") seem to be over 10 years old and could benefit from an update, the recent systemic reviews that you added are perfect. I like your addition about the key differentiating features specific to PDPH. Great job adding malignancy as a contraindication to EBP and for expanding upon the potential complications. To me, those seem to be significant additions to the article with new literature cited. I am not sure if the "effectiveness" section is up to date as I do not see any new references cited, so this could be an area to work on along with the "Special populations" section mentioned above. Rachnasann (talk) 04:00, 15 November 2023 (UTC)
 * Thank you for the feedback! Courseedits23 (talk) 15:12, 15 November 2023 (UTC)